>>update>> 03/14/07: TykerB FDA Approved
Tykerb / GW2016 / lapatinib / is a step closer to market and Xcovery is on it.
They had a C&EN cover back in August, and you can check out the ’06 ASCO report from their renal cell carcinoma Ph iii. (scroll a bit for slides and even a video.) But the highlight from that trial was: 1.25g / day and it didn’t work